Acuerdo Marco del Suministro del MEDICAMENTO RANIBIZUMAB
Awarded
The competition has ended and a winner has been selected.
- Deadline
- Jun 7,Expired
- Award
- Calidad 50%
Brief
El Consorci de Salut i d'Atenció Social de Catalunya ha celebrado un acuerdo marco con NOVARTIS FARMACEUTICA, S.A., ORION PHARMA, S.L. y TEVA PHARMA para el suministro del medicamento RANIBIZUMAB. La adjudicación se basó en criterios de precio (50%) y calidad (50%).
Farmasøytisk engroshandel
Result
- NOVARTIS FARMACEUTICA, S.A.Winner
- ORION PHARMA, S.L.Winner
- TEVA PHARMAWinner
- 3Number of bids
- €0Contract value
- Maximum framework agreement valueUp to €930,000
Custom Assessment Criteria
Get answers to your bid/no-bid criteria
Set them up once and Cobrief answers them in every tender
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
CRITERIOS DE ADJUDICACIÓN A VALORAR EN EL ACUERDO MARCO (100 PUNTOS), CRITERIO EVALUABLE DE FORMA AUTOMÁTICA - Detallado en el QCE de la licitación
Source
No source found in the documents. Check the weight against the tender documents.
Description
CRITERIOS DE ADJUDICACIÓN A VALORAR EN EL ACUERDO MARCO (100 PUNTOS), CRITERIO EVALUABLE DE FORMA AUTOMÁTICA - Detallado en el QCE de la licitación
Source
No source found in the documents. Check the weight against the tender documents.
Previous winners
Who are you up against?
The suppliers who have won similar contracts at Consorci de Salut i d'Atenció Social de Catalunya
From the notice
Acuerdo Marco del Suministro del Medicamento RANIBIZUMAB
Contact
sacac@consorci.org- Result · Framework agreementType
- 33690000Main codeVarious medicinal products